Articular Cartilage Defect
12
6
7
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
42%
5 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (12)
Study Comparing Two Methods for the Treatment of Large Chondral and Osteochondral Defects of the Knee
Introduction of ACI for Cartilage Repair
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
AMIC Compared With Microfracture for Focal Articular Cartilage Damage of the Hip
NOVOCART 3D Treatment Following Microfracture Failure
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
A Comparison of JointRep® and Microfracture in Repair of Cartilage Lesions on the Femoral Condyle or Trochlea,
Autologous Costal Osteochondral Transplantation for Talar Osteochondral Lesions
Phase 2 Clinical Trial of CartiLife® in the United States
Phase 3 Clinical Trial of CartiLife® in Korea
Superiority of MACI® Versus Microfracture Treatment in Patients With Symptomatic Articular Cartilage Defects in the Knee
A Study to Compare Two Techniques for Articular Cartilage Repair:ACIC Vs. MCIC